Intellectual Property Rights

Intellectual Property Rights (IPR) are legal rights granted to creators and inventors to protect their creations and inventions from unauthorized use. They provide exclusive rights to control the commercial exploitation of their work for a specific period. In India, IPR is primarily governed by statutes like the Patents Act, 1970, and the Copyright Act, 1957. The National IPR Policy, adopted in 2016, aims to create an innovation-conducive environment.

The Patents Act 1970, as amended in 2005 to comply with TRIPS agreement, grants patents for inventions that are novel, involve an inventive step, and are capable of industrial application. A patent is typically granted for 20 years from the date of filing. The Copyright Act 1957 protects literary, dramatic, musical, and artistic works, as well as cinematograph films and sound recordings. Copyright protection generally lasts for the lifetime of the author plus 60 years.

Compulsory licensing is a provision under the Patents Act that allows the government to authorize a third party to produce, use, or sell a patented invention without the patent holder's consent, typically in cases of public interest or emergency. 'Evergreening' refers to the practice of making minor modifications to an existing patent to extend its term of protection, which is often challenged in India. Patent trolling involves acquiring patents solely to assert them against others, often without any intention of developing or commercializing the patented technology.

From an exam perspective, understand the key provisions of the Patents Act and the Copyright Act, especially concerning eligibility criteria, duration of protection, and exceptions. Be aware of the implications of TRIPS agreement on Indian patent law. For Mains, be prepared to discuss the balance between IPR protection and access to affordable medicines, the role of IPR in promoting innovation, and the challenges of enforcing IPR in India. Prelims MCQs often test knowledge of specific timelines (e.g., patent duration) and definitions (e.g., compulsory licensing).

A 'Process Patent' only protects the specific method of making a product. Others can make the same product using a different method. A 'Product Patent' protects the final product itself, regardless of how it was made. India only had process patents for food and medicine until 2005. Now, India grants both types, providing stronger protection to inventors. This change was necessary to meet World Trade Organization (WTO) requirements.

A GI tag is a sign used on products that have a specific geographical origin. These products possess qualities or a reputation that are due to that place of origin. It ensures that only authorized users in that area can use the name. This protects traditional products from being copied by outsiders. For example, 'Kashmiri Saffron' has a GI tag because its unique quality is linked to the climate and soil of Kashmir.

A patent is an exclusive right granted by the government for a new invention. It must be something that has never been done before and must be useful. It gives the owner the power to stop others from making, using, or selling the invention for 20 years. In return, the inventor must share the details of how the invention works with the public. For example, a company that discovers a new chemical to cure a disease will apply for a patent to earn back their research costs.

Copyright is a legal term used to describe the rights that creators have over their literary and artistic works. This includes books, music, paintings, sculpture, films, and even computer programs. It starts the moment the work is created. It protects the expression of an idea, not the idea itself. For example, if you write a story about a flying boy, someone else can also write about a flying boy, but they cannot copy your exact words or sentences.

This is a special power of the government to bypass a patent. It allows the state to give a license to a third party to produce a patented drug without the owner's consent. This is done during health emergencies or when the drug is too expensive. The patent owner still receives a small royalty. India issued its first such license to Natco Pharma for a cancer drug called Nexavar because the original price was too high for the public.

Evergreening is a strategy used by companies to extend their patent life beyond 20 years. They do this by making minor, non-inventive changes to an existing product. In India, Section 3(d) of the Patents Act strictly prohibits this practice. This ensures that medicines become affordable as 'Generics' once the original 20-year patent expires. For example, changing a medicine from a tablet to a capsule without improving its effectiveness is considered evergreening and is rejected.